Serial Number 79312732
Registration 6688686
700

Registration Progress

Application Filed
Apr 13, 2021
Under Examination
Approved for Publication
Jan 18, 2022
Published for Opposition
Jan 18, 2022
Registered
Apr 5, 2022

Trademark Image

Basic Information

Serial Number
79312732
Registration Number
6688686
Filing Date
April 13, 2021
Registration Date
April 5, 2022
Published for Opposition
January 18, 2022
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 5, 2022
Registration
Registered
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Original Registrant
03
JP

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
830 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20220405)
Due Date
April 05, 2028
Grace Period Ends
October 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Sep 12, 2022 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 25, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 25, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 5, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 5, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 18, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 18, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2022 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Dec 29, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 29, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Dec 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 30, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 29, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 29, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 23, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 4, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 4, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Oct 14, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Oct 13, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 4, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 12, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 11, 2021 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jun 10, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors; chemical reagents for medical purposes in the field of oncology
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a shaded polygon with eight spokes cutting into the border, with an inner darker lined border and in the middle is a shaded diamond with a darker inner lined border with four spokes around the border and a shaded circle inside.

Classification

International Classes
005